Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC)
Conditions
Non-small Cell Lung Cancer
Conditions: official terms
Carcinoma, Non-Small-Cell Lung - Lung Neoplasms
Conditions: Keywords
BAI, 3DCRT
Study Type
Interventional
Study Phase
N/A
Study Design
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Intervention
Name: Gemcitabine, Nedaplatin, iV Type: Drug
Name: 3DCRT Type: Radiation
Name: 3DCRT Type: Radiation
Name: Gemcitabine,Nedaplatin, BAI Type: Drug
Overall Status
Recruiting
Summary
The purpose of this study is to investigate the efficacy of BAI Plus 3DCRT in local advanced NSCLC.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 70 Years
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- stage IIIA&IIIB NSCLC

- male or female, Age ≥18Years, ≤70Years

- Life expectation of at least 12weeks.

- PS performance 0-2

- Measurable disease according to the Response Evaluation Criteria in Solid Tumours ( RECIST)

Exclusion Criteria:

- Patient with prior chemotherapy or radiology for IIIA or IIIB NSCLC
Location
The 3rd Affiliated Hospital of the 3rd Military Hospital
Chongqing, China
Status: Recruiting
Contact: Yi Li - +86-13452081471
Start Date
January 2010
Completion Date
December 2012
Sponsors
Third Military Medical University
Source
Third Military Medical University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page